• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】10184

【品名】1H-1,2,3-Benzotriazol-1-ol; 1-Hydroxybenzotriazole; 1H-Benzotriazol-1-ol; 1-Benzotriazolol

【CA登记号】2592-95-2

【 分 子 式 】C6H5N3O

【 分 子 量 】135.12532

【元素组成】C 53.33% H 3.73% N 31.1% O 11.84%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(V)

The synthesis of [14C]-labeled cefepime has been reported: The cyclization of [14C]-thiourea (I) with 4-bromo-2-(methoxyimino)-3-oxobutyric acid ethyl ester (II) in ethanol gives 2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid ethyl ester (III), which is hydrolyzed with NaOH in methanol to the corresponding free acid (IV). The esterification of (IV) with 1-hydroxybenzotriazole (V) by means of dicyclohexylcarbodiimide in THF affords the corresponding active ester (VI), which is condensed with 7-amino-3-(1-methylpyrrolidiniomethyl)-3-cephem-4-carboxylate (VII) by means of NaOH in THF-water and isolated as the sulfate salt (VIII). Finally, this compound is treated with triethylamine in N-methyl-2-pyrrolidone.

1 Swigor, J.E.; Standridge, R.T.; Synthesis of 7-[alpha-(2-amino-[2-14C]thiazol-4-yl)-alpha-(Z)-methoxyiminoacetamido]-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hydrochloride ([14C]cefepime hydrochloride). J Label Compd Radiopharm 1993, 33, 8, 759.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10180 Thiourea 62-56-6 CH4N2S 详情 详情
(I) 44602 thiourea CH4N2S 详情 详情
(II) 10181 ethyl 4-bromo-2-(methoxyimino)-3-oxobutanoate 60845-87-6 C7H10BrNO4 详情 详情
(III) 10182 Ethyl 2-(2-aminothiazole-4-yl)-2-methoxyiminoacetate; ethyl 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetate; 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic acid ethyl ester 64485-88-7 C8H11N3O3S 详情 详情
(III) 44603 ethyl 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetate C8H11N3O3S 详情 详情
(IV) 10183 (Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetic acid;2-(2-Amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetic acid 66338-96-3 C5H5N3O3S 详情 详情
(IV) 44604 2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetic acid C5H5N3O3S 详情 详情
(V) 10184 1H-1,2,3-Benzotriazol-1-ol; 1-Hydroxybenzotriazole; 1H-Benzotriazol-1-ol; 1-Benzotriazolol 2592-95-2 C6H5N3O 详情 详情
(VI) 10185 1-(2-Amino-1,3-thiazol-4-yl)-2-(1H-1,2,3-benzotriazol-1-yloxy)-2-oxo-1-ethanone oxime C11H8N6O3S 详情 详情
(VI) 44605 1-(2-amino-1,3-thiazol-4-yl)-2-(1H-1,2,3-benzotriazol-1-yloxy)-2-oxo-1-ethanone oxime C11H8N6O3S 详情 详情
(VII) 10186 (6R,7R)-7-amino-3-[(1-methyltetrahydro-1H-pyrrolium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C13H19N3O3S 详情 详情
(VIII) 10187 1-[((6R,7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-1-methyltetrahydro-1H-pyrrolium C19H25N6O5S2 详情 详情
(VIII) 44606 1-[((6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-1-methylpyrrolidinium C19H25N6O5S2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VIb)

Treatment of 6-methoxy-1,4-dimethylcarbazole (I) with pivaloyl chloride and NaI in refluxing acetonitrile cleaved the methyl ether and afforded pivalate (II). The condensation of this with the Vilsmeier reagent from N-methylformanilide and phosphoryl chloride gave the formyl compound (III). Condensation of (III) with aminoacetaldehyde diethyl acetal in the presence of a catalytic amount of p-toluenesulfonic acid in refluxing toluene with azeotropic distillation of water, followed by hydrogenation of the intermediate imine in the presence of PtO2, afforded the corresponding amine, which was subsequently converted to the N-tosyl derivative (IV) on treatment with tosyl chloride and triethylamine. Refluxing (IV) with hydrogen chloride in aqueous dioxane effected cyclization, with simultaneous elimination of the tosyl and pivaloyl groups yielding the 9-hydroxyellipticine (V) (1). Glutaric acid monobenzyl ester (VIa) was converted to the active ester (VII) on treatment with 1-hydroxybenzotriazole (VIb) and dicyclohexyl carbodiimide, and this was condensed with (V) to afford diester (VIII). Finally, the benzyl ester was deprotected by hydrogenolysis in the presence of palladium-carbon and hydrogen.

1 Harada, N.; et al.; Synthesis and antitumor activity of 9-acyloxyellipticines. Chem Pharm Bull 1997, 45, 7, 1156.
2 Tsujihara, K.; Harada, N.; Ozaki, K.; Ohashi, M.; Oda, K. (Tanabe Seiyaku Co., Ltd.); Ellipticine derivs. with antitumor activity. EP 0608876; JP 1994279441; US 5605904 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIb) 10184 1H-1,2,3-Benzotriazol-1-ol; 1-Hydroxybenzotriazole; 1H-Benzotriazol-1-ol; 1-Benzotriazolol 2592-95-2 C6H5N3O 详情 详情
(VIa) 19943 5-(benzyloxy)-5-oxopentanoic acid C12H14O4 详情 详情
(I) 19938 5,8-dimethyl-9H-carbazol-3-yl methyl ether; 6-methoxy-1,4-dimethyl-9H-carbazole C15H15NO 详情 详情
(II) 19939 5,8-dimethyl-9H-carbazol-3-yl pivalate C19H21NO2 详情 详情
(III) 19940 6-formyl-5,8-dimethyl-9H-carbazol-3-yl pivalate C20H21NO3 详情 详情
(IV) 19941 6-([(2,2-diethoxyethyl)[(4-methylphenyl)sulfonyl]amino]methyl)-5,8-dimethyl-9H-carbazol-3-yl pivalate C33H42N2O6S 详情 详情
(V) 19942 5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol hydrochloride C17H15ClN2O 详情 详情
(VII) 19944 benzyl 5-(1H-1,2,3-benzotriazol-1-yloxy)-5-oxopentanoate C18H17N3O4 详情 详情
(VIII) 19945 1-benzyl 5-(5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-yl) pentanedioate C29H26N2O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

The synthesis of FK-463 can be performed as follows: The enzymatic deacylation of FR-901379 with Streptomyces anulatas No. 4811, S. anulatas No. 8703, Streptomyces strain No. 6907 or A. utahensis IFO13244 gives the deacylated lipopeptide FR-179642 (1), which is then reacylated with 1-[4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoyl]benzotriazole 3-oxide (VI) by means of dimethylaminopyridine (DMAP) in DMF. The acylating compound (VI) can be obtained as follows: The cyclization of 4-pentyloxyphenylacetylene (I) with 4-(hydroxyiminomethyl)benzoic acid methyl ester (II) by means of triethylamine in hot THF gives 4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoic acid methyl ester (III), which is hydrolyzed with NaOH in hot THF/water yielding the corresponding free acid (IV). Finally, this compound is condensed with 1-hydroxybenzotriazole (V) by means of 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDMCA) in dichloromethane.

1 Ueda, S.; Ezaki, M.; Tanaka, M.; et al.; Studies on a novel lipopeptide acylase from Streptomyces spp. for production of FR179642, a key intermediate of antifungal lipopeptide drug FK463. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-145.
2 Fromtling, R.A.; Castañer, J.; FK-463. Drugs Fut 1998, 23, 12, 1273.
3 Ohki, H.; Tomishima, M.; Yamada, A.; Takasugi, H. (Fujisawa Pharmaceutical Co., Ltd.); Cyclic hexapeptides having antibiotic activity. EP 0788511; JP 1998324695; JP 1998507174; US 6107458; WO 9611210 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(F- 901379) 19224 sodium (2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-23-[(1S,2S)-1,2-dihydroxy-2-[4-hydroxy-3-(sulfonatooxy)phenyl]ethyl]-2,11,12,15-tetrahydroxy-6-[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxo-9-(palmitoylamino)tetracosahydro-1H-dipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosine C51H81N8NaO21S 详情 详情
(FR-179642) 19225 (2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-9-Amino-20-(3-amino-1(R)-hydroxy-3-oxopropyl)-23-[1(S),2(S)-dihdyroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl]-2,11,12,15-tetrahydroxy-6-(1(R)-hydroxyethyl)-16-methylperhydrodipyrrolo[2,1-c:2,1-f][1,4,7,10,13,16]hexaazacyclohenicosine-5,8,14,19,22,25-hexaone C35H51N8NaO20S 详情 详情
(I) 19218 4-ethynylphenyl pentyl ether; 1-ethynyl-4-(pentyloxy)benzene C13H16O 详情 详情
(II) 19219 methyl 4-[(hydroxyimino)methyl]benzoate C9H9NO3 详情 详情
(III) 19220 methyl 4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoate C22H23NO4 详情 详情
(IV) 19221 4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoic acid C21H21NO4 详情 详情
(V) 10184 1H-1,2,3-Benzotriazol-1-ol; 1-Hydroxybenzotriazole; 1H-Benzotriazol-1-ol; 1-Benzotriazolol 2592-95-2 C6H5N3O 详情 详情
(VI) 19223 3-(4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl)-3H-1,2,3-benzotriazol-1-ium-1-olate C27H24N4O4 详情 详情
Extended Information